CYFIP1

Cytoplasmic FMR1-interacting protein 1 · Q7L576 · CYFIP1 on Sugi Atlas →

0 patent compounds predicted against CYFIP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CYFIP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Riluzole in Fragile X Syndrome PHASE4COMPLETED
Randomized Controlled Study of Donepezil in Fragile X Syndrome PHASE2COMPLETED
An Open-Label Trial of Donepezil in Fragile X Syndrome PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X Syndrome nanUNKNOWN
Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation nanCOMPLETED
Optical Imaging as a Tool for Monitoring Brain Function in Fragile X Syndrome nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
Examining Physiology and Brain Function in People With the Fragile X Premutation nanCOMPLETED
Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder nanRECRUITING
Various Type of Genetic Events in Patients With Intellectual Disability nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Blood-based Biomarkers for the Prognosis of Sports Related Concussion nanCOMPLETED
Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked nanUNKNOWN
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic nanCOMPLETED
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
The Role of Epigenetic Modifications in Autism Spectrum Disorder nanUNKNOWN
Decisional Capacity and Informed Consent in Fragile X Syndrome nanCOMPLETED
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures. nanUNKNOWN
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes nanRECRUITING
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
FA Clinical Outcome Measures nanACTIVE_NOT_RECRUITING
Immune Cell Response to Stimuli nanRECRUITING
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CYFIP1 binder may also engage these)

ProteinNameSimilarity
Q7TMB8 1.000 Q7TMB8 →
Q5SQX6 1.000 Q5SQX6 →
Q6GQD1 1.000 Q6GQD1 →
Q90YM8 1.000 Q90YM8 →
Q5R414 1.000 Q5R414 →
Q9VF87 1.000 Q9VF87 →
P55162 1.000 P55162 →
Q299G2 1.000 Q299G2 →
O44518 1.000 O44518 →
CYFIP2 Cytoplasmic FMR1-interacting protein 2 1.000 landscape →
A7RU46 0.999 A7RU46 →
Q8K1X4 0.998 Q8K1X4 →
P55163 0.995 P55163 →
NCKAP1L Nck-associated protein 1-like 0.995 landscape →
Q9VUY8 0.994 Q9VUY8 →
Q54IR8 0.993 Q54IR8 →
Q6UK63 0.992 Q6UK63 →
Q5S2C3 0.991 Q5S2C3 →
Q640K3 0.991 Q640K3 →
Q16X15 0.991 Q16X15 →
A1CXW3 0.991 A1CXW3 →
Q5F3M0 0.989 Q5F3M0 →
Q8WVF1 0.988 Q8WVF1 →
Q5ZLS8 0.988 Q5ZLS8 →
Q4WNQ6 0.988 Q4WNQ6 →
Q7ZVM1 0.988 Q7ZVM1 →
Q9JHU4 0.988 Q9JHU4 →
Q24134 0.988 Q24134 →
DYNC1H1 Cytoplasmic dynein 1 heavy chain 1 0.988 landscape →
P78716 0.988 P78716 →